Making CAR T-Cell Therapy Safer – The Scientist
|
Making CAR T-Cell Therapy Safer
The Scientist JCAR015 is not the first CAR T-cell therapy to have been associated with patient deaths. In fact, even those trials considered a success sometimes have troubling safety profiles. For example, Novartis's lead candidate, the CD19-targeting CLT019, … |
